Processa Pharmaceuticals, Inc. Dividends, Preferred Stock, Paid-in-kind
Processa Pharmaceuticals, Inc. (PCSA) reported Dividends, Preferred Stock, Paid-in-kind of $1.33 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-06-19.
Discontinued › Shareholders' Equity › Dividends › Dividends, Preferred Stock
us-gaap:DividendsPreferredStockPaidinkind · last filed 2017-06-19
- Processa Pharmaceuticals, Inc. dividends, preferred stock, paid-in-kind for the quarter ending 2014-12-31 was $1.31M.
- Processa Pharmaceuticals, Inc. dividends, preferred stock, paid-in-kind for the quarter ending 2014-09-30 was $26.83K.
- Processa Pharmaceuticals, Inc. dividends, preferred stock, paid-in-kind for fiscal 2014 was $1.33M.
| Period end | Dividends, Preferred Stock, Paid-in-kind 3 month | Dividends, Preferred Stock, Paid-in-kind 6 month | Dividends, Preferred Stock, Paid-in-kind 9 month | Dividends, Preferred Stock, Paid-in-kind 12 month |
|---|---|---|---|---|
| 2014-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $1.33M derived: sum of 2 quarters · filed 2017-06-19 | $1.33M 10-K · filed 2017-06-19 | |
| 2014-09-30 | $26.83K 10-Q · filed 2015-12-01 | $26.83K 10-Q · filed 2015-12-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |